Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study

被引:16
作者
Hashash, Jana G. [1 ,2 ,5 ]
Desai, Aakash [3 ]
Kochhar, Gursimran S. [4 ]
Farraye, Francis A. [1 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Jacksonville, FL 32224 USA
[2] Amer Univ Beirut, Div Gastroneterol & Hepatol, Beirut, Lebanon
[3] Case Western Reserve Univ, Metrohlth Med Ctr, Div Gastroenterol & Hepatol, Cleveland, OH USA
[4] Allegheny Hlth Network, Div Gastroenterol & Hepatol, Pittsburgh, PA USA
[5] Mayo Clin, Inflammatory Bowel Dis Ctr, Div Gastroenterol & Hepatol, San Pablo Rd, Jacksonville, FL 32224 USA
关键词
D O I
10.1016/j.cgh.2022.09.011
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:841 / +
页数:7
相关论文
共 8 条
[1]  
[Anonymous], XELJANZXELJANZ XRXEL
[2]  
[Anonymous], Nonhospitalized Adults: Therapeutic Management
[3]   Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients [J].
Bernal, A. Jayk ;
da Silva, M. M. Gomes ;
Musungaie, D. B. ;
Kovalchuk, E. ;
Gonzalez, A. ;
Delos Reyes, V ;
Martin-Quiros, A. ;
Caraco, Y. ;
Williams-Diaz, A. ;
Brown, M. L. ;
Du, J. ;
Pedley, A. ;
Assaid, C. ;
Strizki, J. ;
Grobler, J. A. ;
Shamsuddin, H. H. ;
Tipping, R. ;
Wan, H. ;
Paschke, A. ;
Butterton, J. R. ;
Johnson, M. G. ;
De Anda, C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (06) :509-520
[4]  
fda, NEWS EV
[5]  
gastroendonews, ONL 1 ART
[6]   Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 [J].
Hammond, Jennifer ;
Leister-Tebbe, Heidi ;
Gardner, Annie ;
Abreu, Paula ;
Bao, Weihang ;
Wisemandle, Wayne ;
Baniecki, MaryLynn ;
Hendrick, Victoria M. ;
Damle, Bharat ;
Simon-Campos, Abraham ;
Pypstra, Rienk ;
Rusnak, James M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (15) :1397-1408
[7]  
Najjar-Debbiny R, 2022, CLIN INFECT DIS
[8]  
Paxlovid (nirmatrelvir and ritonavir), EMERGENCY USE AUTHOR